A family history of cancer and genetic variants that might be inherited appear to be important risk factors for Black men diagnosed with early-onset prostate cancer, a study involving Duke Health researchers has found.
28-Nov-2022 3:40 PM EST Add to Favorites
This news release is embargoed
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.
22-Nov-2022 11:55 AM EST Add to Favorites
A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.
18-Nov-2022 11:00 AM EST Add to Favorites
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.
14-Nov-2022 1:05 PM EST Add to Favorites
In the battle of the sexes, women beat men in their ability to recover from kidney injury, but the reasons are not well understood. A study led by Duke Health researchers provides some insights: Females, it turns out, have an advantage at the...
3-Nov-2022 1:05 PM EDT Add to Favorites
A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset...
6-Nov-2022 6:30 PM EST Add to Favorites
For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery. A new study is providing a bit more clarity, suggesting there are some benefits for...
6-Nov-2022 9:15 AM EST Add to Favorites
In a head-to-head comparison of two so-called ‘water pills’ that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.
5-Nov-2022 10:30 AM EDT Add to Favorites
See All News
Experts from @DukeHealth: FDA Approval of First Postpartum Depression Drug Could Be a ‘Game-Changer’ #zulresso #brexanolone #allopregnanolone
19-Mar-2019 5:05 PM EDT
12-Feb-2019 12:05 PM EST
26-Oct-2017 2:05 PM EDT
8-Sep-2017 9:00 AM EDT
4-Aug-2017 8:05 AM EDT
17-Dec-2015 9:05 AM EST
18-Feb-2015 8:00 AM EST
9-Feb-2015 9:50 AM ESTSee All Experts